Lester Crawford was confirmed as the head of the FDA on July 18, 2005 and resigned two months later on September 23, 2005. His confirmation had been held up until he promised to act on the application to make the Plan B contraceptive over the counter but once in he reneged on the deal and postponed a decision. His sudden resignation, however, stemmed from a series of false statements and conflicts of interest. He failed to disclose $28,000 in stock options from a poultry biotechnology company Embrex on whose board he had sat. He stated falsely in a 2004 filing that he had divested his holdings in the food services giant Sysco and Kimberly-Clark (which makes Kleenex). In a clear conflict of interest, he chaired the FDA’s Obesity Working Group while at the same time holding stock in Sysco and Pepsico. On October 17, 2006, he pled guilty to two misdemeanors. He was sentenced on February 27, 2007 to 3 years probation and a $90,000 fine.